Lumex announces the global launch of its first-in-the-industry QuantumBrite Shapeable LED Backlight. With the new shapeable LED backlight, holes can be cut into the backlight in virtually any shape (for example, to allow space for a switch or other component on the circuit board).
The Lee Company’s new LPL2 Inert Solenoid Pump was designed to offer greater design flexibility and significant cost savings to the medical and scientific industries.
WIRRAL, U.K.--(BUSINESS WIRE)--Aug 30, 2012--LDRA, the leading provider of automated software verification, source code analysis and test tools, has been selected by Esprit Lean to prove compliance of medical technology being developed to assist in cancer treatment. Esprit Lean chose the LDRA tool...
Missed medical conditions, which may account for as many annual deaths as breast cancer, are an underrated preventable cause of death, according to Johns Hopkins researchers. MASSDEVICE ON CALL — Medical errors in the intensive care unit may kill as many as 40,500 patients per year, putting diagnostics on par with breast cancer for patient mortality, according to a new study. The problem is pervasive yet under-appreciated, researchers concluded based on studies of more than 5,800 autopsy reports from a wide variety of ICU types. News Well, Breast Cancer, On Call, Research & Developmentread more
Biomerica Announces Year End Results: Sales up Over 24%; Net Income $0.08 per Share Versus $0.02 per ShareAugust 30, 2012 8:21 am | by The Associated Press | News | Comments
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net income of $548,435, or $0.08 per share, for the fiscal year ended May 31, 2012, compared to net income of $157,447, or $0.02 per share, in fiscal...
UNION CITY, Calif., Aug. 30, 2012 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer , will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 11, 2012 at 4:30 p.m. ET. The conference will be held at the Grand Hyat...
Zynex, Inc. (OTCBB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it received FDA 510(k) clearance on its InWave medical device. The InWave device is the newest...
Medical device giant Boston Scientific expects an untold number of layoffs in the next few months and the company will its cardiac device businesses into separate CRM and stent divisions. Medtech titan Boston Scientific (NYSE:BSX) is making some big moves in the next few months, including some new rounds of layoffs and the halving of its cardiac devices business, Reuters reported. The news was leaked by an anonymous Boston Scientific employee and later confirmed by a company spokesperson, who noted that the layoffs and the cardiac division split are not related. News Well, Cardiac Rhythm Management, Cardiovascular, Layoffs, Stents, Wall Street Beatread more
In a leap forward for viral medicine no less important than the first studies in HIV decades ago, Medgenics, Inc. (AMEX:MDGN) is set to begin two human clinical trials for its INFRADURE Biopump to test a continuous release of naturally-produced interferon alpha for hepatitis C. This may, perhaps...
Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) of Cambridge has submitted its lead compound, ponatinib, which targets a rare form of leukemia, for approval in Europe.
Public Meeting - Strengthening the National Medical Device Postmarket Surveillance System, September 10, 2012August 30, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments
The purpose of this meeting is to solicit public feedback regarding FDA?s proposal to strengthen the national medical device postmarket surveillance system.
Public Workshop - Leveraging Registries With Medical Device Data for Postmarket Surveillance and Evidence Appraisal Throughout the Total Product Life Cycle, September 12-13, 2012August 30, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments
The topic to be discussed is best practices for use of registries with medical device data for postmarket surveillance, clinical studies, and evidence appraisal.
Woburn-based biotech company ArQule Inc. has learned that partner Kyowa Hakko Kirin Co., Ltd., which has exclusive development rights to ArQule’s lead product candidate tivantinib in Japan, has suspended patient enrollment in its ongoing Phase 3 trial dubbed ATTENTION.
Infertility treatment startup OvaScience Inc. has filed a registration statement with the U.S. Securities and Exchange Commission to go public on the Over The Counter Bulletin Board (OTCBB) or another informal exchange.
Life sciences company EMD Millipore, a division of Merck KGaA of Germany, has donated $10,000 to charity: water, a nonprofit focused on bringing safe drinking water to people in developing nations.